Femtech Market Size Worth US$ 151.67 Billion by 2033

At a Glance

Report Coverage

56 +

Countries

56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa

Year Assessment

Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)

10 +

Major Players

Major companies profiled including HeraMED, Magnolia Collective Wellness, Sirona Hygiene Private Limited, Natural Cycles USA Corp, Sehati TeleCTG

400

Report Pages

Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets

What's Fueling Growth

Market Drivers

Rising awareness of gender-specific health needs
Surging venture capital funding for women startups
Expanding adoption of wearable diagnostic devices

Where Growth Opportunities Exist

Key Opportunities

Scaling AI-powered personalized hormone modeling
Expanding employer-sponsored women\\\'s health plans
Developing remote care for underserved rural regions

What Could Slow It Down

Market Restraints

Heightened concerns over sensitive data privacy
Fragmented global regulatory and approval pathways
High costs of advanced fertility and menopause tech

Market Segmentation

Coverage by Segment

Type

Products(Wearables

Fertility and Hormone Monitoring Kits

Sexual Wellness Devices

Application

Pregnancy and Nursing Care

Reproductive Health

General Health and Wellness

End user

Hospitals

Fertility Clinics

Diagnostic Centers

Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

HeraMED

Magnolia Collective Wellness

Sirona Hygiene Private Limited

Natural Cycles USA Corp

Sehati TeleCTG

Ira Concept Co. Ltd.

Lumirous Sdn. Bhd

WomenX Biotech

Blissmi

Twoplus Fertility

What's Inside

Report Scope & Deliverables

Market Size 2025	US$ 58.22 Billion
Market Size 2033	US$ 151.67 Billion
CAGR 2026–2033	12.71%
Segments	By Type (Products(Wearables, Fertility and Hormone Monitoring Kits, Sexual Wellness Devices) \| By Application (Pregnancy and Nursing Care, Reproductive Health, General Health and Wellness) \| By End user (Hospitals, Fertility Clinics, Diagnostic Centers)
Geographies	North America (US, Canada, Mexico) · Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom) · Asia-Pacific (Australia, China, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Bangladesh, New Zealand, Taiwan) · South and Central America (Brazil, Argentina, Peru, Chile, Colombia) · Middle East and Africa (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Turkiye, South Africa, Egypt, Algeria, Nigeria)
Deliverables	Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code	BMIPUB00032447
Lead Analyst	Krishna Sunthwal — Analyst, Research · View Profile

With Full Report Access

Gain actionable insights with 400 pages of in-depth Femtech Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample

Femtech Market Size & Forecast

Report Coverage

Market Drivers

Rising awareness of gender-specific health needs

Surging venture capital funding for women startups

Expanding adoption of wearable diagnostic devices

Key Opportunities

Scaling AI-powered personalized hormone modeling

Expanding employer-sponsored women\\\'s health plans

Developing remote care for underserved rural regions

Market Restraints

Heightened concerns over sensitive data privacy

Fragmented global regulatory and approval pathways

High costs of advanced fertility and menopause tech